We are live on ! Find out more
HRMY icon

Harmony Biosciences
HRMY

59 hedge funds and large institutions have $998M invested in Harmony Biosciences in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 14

34% more funds holding

Funds holding: 44 → 59 (+15)

8% more capital invested

Capital invested by funds: $926M → $998M (+$71.4M)

4.31% more ownership

Funds ownership: 44.83% → 49.14% (+4.3%)

8% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 12

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
59
Holders Change
+15
Holders Change %
+34.09%
% of All Funds
1.04%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
29
Increased
13
Reduced
12
Closed
14
Calls
$159K
Puts
–
Net Calls
+$159K
Net Calls Change
+$159K

Top Buyers

Rank Fund Capital Flow
1
ACM
Ashford Capital Management
Delaware
+$11M
2
SPPAM
Summit Partners Public Asset Management
Massachusetts
+$10.4M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$8.86M
4
BlackRock
BlackRock
New York
+$7.6M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$7.42M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$45.9M
2
Millennium Management
Millennium Management
New York
-$10.9M
3
BBA
Baker Bros. Advisors
New York
-$8.88M
4
Citadel Advisors
Citadel Advisors
Florida
-$7.75M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
51
Citigroup
New York
$48K +$53.2K +1,319 New
Bank of Montreal
52
Bank of Montreal
Ontario, Canada
$35K +$39.4K +975 New
Legal & General Group
53
Legal & General Group
United Kingdom
$23K +$25.5K +631 New
AIP
54
Ameritas Investment Partners
Nebraska
$19K +$21K +520 New
Osaic Holdings
55
Osaic Holdings
Arizona
$9K – – –
EWA
56
Evolution Wealth Advisors
Florida
$9K +$9.85K +244 New
TRCT
57
Tower Research Capital (TRC)
New York
$7K -$122K -3,034 -94%
Royal Bank of Canada
58
Royal Bank of Canada
Ontario, Canada
$2K +$2.26K +56 New
AIG
59
American International Group
New York
$131 +$146K +3,610 New
T. Rowe Price Associates
60
T. Rowe Price Associates
Maryland
– -$7.1M -209,361 Closed
First Trust Advisors
61
First Trust Advisors
Illinois
– -$2.07M -61,030 Closed
MA
62
MYDA Advisors
New York
– -$1.11M -32,782 Closed
TD Asset Management
63
TD Asset Management
Ontario, Canada
– -$798K -23,544 Closed
PCM
64
Pinz Capital Management
New York
– -$492K -14,500 Closed
MFS
65
Mirabella Financial Services
United Kingdom
– -$482K -14,232 Closed
SCM
66
Suvretta Capital Management
New York
– -$424K -12,500 Closed
Russell Investments Group
67
Russell Investments Group
United Kingdom
– -$414K -12,275 Closed
AWE
68
Avidian Wealth Enterprises
Texas
– -$407K -12,000 Closed
Squarepoint
69
Squarepoint
New York
– -$355K -10,461 Closed
MS
70
Maven Securities
Jersey
– -$206K -6,277 Closed
Tudor Investment Corp
71
Tudor Investment Corp
Connecticut
– -$211K -6,236 Closed
CCM
72
CAAS Capital Management
New York
– -$203K -6,000 Closed
CAL
73
Capital Analysts LLC
Pennsylvania
– -$3K -100 Closed
1 2
3

HRMY Hedge Fund Activity: Q4 2020 in Review

59 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q4 2020, worth a combined $998M — up 7.7% from $926M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new HRMY positions and 14 closed out — a net gain of 15 holders — while 13 added to existing stakes and 12 trimmed.

The largest buyer was Ashford Capital Management, opening a new position worth an estimated $11M. The largest seller was Fidelity Investments, cutting an estimated $45.9M.

  • 59 institutional investors held Harmony Biosciences (HRMY) as of Q4 2020, up from 44 in Q3 2020.
  • Funds reported $998M of Harmony Biosciences stock for Q4 2020, up 7.7% quarter-over-quarter.
  • 29 funds opened new Harmony Biosciences positions in Q4 2020 and 14 closed out, a net change of +15 holders.
  • The largest Harmony Biosciences buyer in Q4 2020 was Ashford Capital Management, an estimated $11M added.
  • The largest Harmony Biosciences seller in Q4 2020 was Fidelity Investments, an estimated $45.9M sold.

Based on aggregated 13F filings for Q4 2020.